Aspartame pharmacokinetics - the effect of ageing

S Puthrasingam; W M Heybroek; A Johnston; V Maskrey; C G Swift; P Turner; S M Abrams; S H Jackson

doi:10.1093/ageing/25.3.217

Aspartame pharmacokinetics - the effect of ageing

S Puthrasingam, W M Heybroek, A Johnston, V Maskrey, C G Swift, P Turner, S M Abrams, S H Jackson

Norwich Medical School

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Aspartame is an intense sweetener which is increasingly used in the UK. It is registered at an acceptable daily intake (ADI) of 40 mg/kg, although there are no previous data relating to the metabolism of aspartame in older people. Twelve young and 12 elderly volunteers each received a single dose of approximately 40 mg/kg of aspartame. Baseline concentrations of phenylalanine (the main metabolite of aspartame) rose after ingestion with a significantly higher maximum concentration (Cmax) (81.3 vs. 63.3 micromol/1, p

Original language	English
Pages (from-to)	217-220
Number of pages	4
Journal	Age and Ageing
Volume	25
Issue number	3
DOIs	https://doi.org/10.1093/ageing/25.3.217
Publication status	Published - May 1996

Keywords

Adult
Aged
Aged, 80 and over
Aging
Aspartame
Female
Humans
Male
Metabolic Clearance Rate
Phenylalanine
Pilot Projects
Reference Values

Access to Document

10.1093/ageing/25.3.217

Cite this

@article{79f7a8f5f63946b18530d5b73894bbc5,

title = "Aspartame pharmacokinetics - the effect of ageing",

abstract = "Aspartame is an intense sweetener which is increasingly used in the UK. It is registered at an acceptable daily intake (ADI) of 40 mg/kg, although there are no previous data relating to the metabolism of aspartame in older people. Twelve young and 12 elderly volunteers each received a single dose of approximately 40 mg/kg of aspartame. Baseline concentrations of phenylalanine (the main metabolite of aspartame) rose after ingestion with a significantly higher maximum concentration (Cmax) (81.3 vs. 63.3 micromol/1, p",

keywords = "Adult, Aged, Aged, 80 and over, Aging, Aspartame, Female, Humans, Male, Metabolic Clearance Rate, Phenylalanine, Pilot Projects, Reference Values",

author = "S Puthrasingam and Heybroek, {W M} and A Johnston and V Maskrey and Swift, {C G} and P Turner and Abrams, {S M} and Jackson, {S H}",

year = "1996",

month = may,

doi = "10.1093/ageing/25.3.217",

language = "English",

volume = "25",

pages = "217--220",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Aspartame pharmacokinetics - the effect of ageing

AU - Puthrasingam, S

AU - Heybroek, W M

AU - Johnston, A

AU - Maskrey, V

AU - Swift, C G

AU - Turner, P

AU - Abrams, S M

AU - Jackson, S H

PY - 1996/5

Y1 - 1996/5

N2 - Aspartame is an intense sweetener which is increasingly used in the UK. It is registered at an acceptable daily intake (ADI) of 40 mg/kg, although there are no previous data relating to the metabolism of aspartame in older people. Twelve young and 12 elderly volunteers each received a single dose of approximately 40 mg/kg of aspartame. Baseline concentrations of phenylalanine (the main metabolite of aspartame) rose after ingestion with a significantly higher maximum concentration (Cmax) (81.3 vs. 63.3 micromol/1, p

AB - Aspartame is an intense sweetener which is increasingly used in the UK. It is registered at an acceptable daily intake (ADI) of 40 mg/kg, although there are no previous data relating to the metabolism of aspartame in older people. Twelve young and 12 elderly volunteers each received a single dose of approximately 40 mg/kg of aspartame. Baseline concentrations of phenylalanine (the main metabolite of aspartame) rose after ingestion with a significantly higher maximum concentration (Cmax) (81.3 vs. 63.3 micromol/1, p

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Aging

KW - Aspartame

KW - Female

KW - Humans

KW - Male

KW - Metabolic Clearance Rate

KW - Phenylalanine

KW - Pilot Projects

KW - Reference Values

U2 - 10.1093/ageing/25.3.217

DO - 10.1093/ageing/25.3.217

M3 - Article

C2 - 8670556

SN - 0002-0729

VL - 25

SP - 217

EP - 220

JO - Age and Ageing

JF - Age and Ageing

IS - 3

ER -